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ABSTRACT 
Objective: Calcium pectinate is an insoluble hydrophilic material used for sustained release delivery. The objective of the study was formulation 
and evaluation pectin-calcium chloride beads of azathioprine.  
Methods: Calibration curves of azathioprine were prepared in 0.1N HCl solution (pH-1.2) and phosphate buffer (pH-6.8 and pH-7.4). Fourier 
transform infrared spectroscopy and differential scanning calorimetry was used to determine compatibility between azathioprine and excipients. 
Formulation and optimization of calcium-pectinate beads were performed. The coating of the optimized batch was performed with eudragit S100. 
Micrometric properties, scanning electron microscopy, in vitro azathioprine release, and stability study was performed. Dissolution kinetic study 
was assessed for various kinetics models of the optimized batch. The Wilcoxon test followed by the Dunnett’s multiple comparison tests were 
performed between uncoated and coated beads in vitro dissolution profile of optimized batch in 0.1N HCl after 2 h.  
Results: Fourier transform infrared spectroscopy and differential scanning calorimetry had identical peaks with that of pure azathioprine in 
compatibility study. Scanning electron microscopy of an uncoated optimized batch of beads indicated the smooth and uniform surface of prepared 
beads. Eudragit S100 coating was decreased release of azathioprine release in 0.1N HCl after 2 h (p = 0.049, q = 3.533). Korsmeyer/Peppa's model 
was applied with release exponent higher than 1. In vitro percentage cumulative azathioprine release was identical before and after stability study. 
Conclusion: Calcium pectinate beads of azathioprine, a multi-particulate dosage form using pH-dependent approaches were prepared.  
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Inflammatory bowel disease (IBD) is a collective term encompassing 
related but distinct chronic inflammatory disorders of the 
gastrointestinal tract such as Crohn's disease, ulcerative colitis, 
indeterminate colitis, microscopic colitis, and collagenous colitis [1]. 
In IBD, colon-specific drug delivery system is preferred dosage form 
because of having advantages of oral administration and site-specific 
action [2]. Colon targeted drugs are more effective in fewer dose [3].  
Pectin is a purified polysaccharide obtained from the diluted acid 
extract of the inner portion of the rind of citrus fruits or from apple 
pomace. It consists chiefly of partially methoxylated poly-
galacturonic acids. The galacturonic acid residues which have 
carboxyl groups are present as methyl esters. Low methoxy pectin 
(with a degree of esterification<50%) from rigid gels by the action of 
calcium which cross-links the galacturonic acid chains. Since pectin 
can react with calcium ions forms calcium pectinate as an insoluble 
hydrophilic material used for sustained release delivery [4]. 
The objective of the study was to formulate and optimize pectin-
calcium chloride beads of azathioprine, compatibility study, coating 
with eudragit S100, and to evaluate micrometric properties, 
scanning electron microscopy, in vitro azathioprine release, and 
stability. 
MATERIALS AND METHODS 
Material 
Azathioprine was purchased from Troikka pharma, Ahmedabad 
India. Pectin and eudragit S100, disodium hydrogen phosphate, 
potassium dihydrogen phosphate, hydrochloric acid (HCl) were 
purchased from Oxford Lab., Mumbai, India. Calcium chloride 
(CaCl2
There was 10 µG/ml solution of azathioprine prepared in 0.1N 
HCl solution (pH-1.2) and phosphate buffer (pH-6.8 and pH-7.4). 
It was scanned using UV Spectrometer (1700 UV/Vis double 
beam, Shimadzu, Japan) and absorbance maximum (λmax) was 
noted in all medium.  
) was purchased from Chem. Lab. India. 
Calibration curve for azathioprine 
There were different solutions (2–30 µG/ml) of it in different 
medium were prepared and absorbance was noted at λmax. 
Calibration curves of azathioprine were prepared in 0.1N HCl 
solution (pH-1.2) and phosphate buffer (pH-6.8 and pH-7.4).  
Compatibility studies between azathioprine and excipients 
Fourier transform infrared spectroscopy (FTIR) and differential 
scanning calorimetry (DSC) was used to determine compatibility 
between azathioprine and excipients.  
DSC study 
The samples of pure azathioprine and azathioprine-pectin mixtures 
were prepared to investigate the molecular state of the azathioprine 
using differential scanning calorimeter (DSC-60, Shimadzu, Japan). 
Each sample was sealed in an aluminum pan and heated at a 
constant rate (10.0 °C/min) over a temperature range of 10–350 °C 
under a nitrogen purge of 20 ml/min [5]. 
FTIR study 
FTIR (Shimadzu, Japan) was performed for qualitative and 
structural identification of azathioprine and azathioprine-pectin 
mixtures. Each sample was placed in the compartment and 
identical spectrum was generated. Comparisons were carried out 
between the spectrum of pure azathioprine and azathioprine-
pectin mixture [6].  
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Formulation and optimization of calcium-pectinate beads 
Pectin was dissolved in distilled water with continues agitation. 
Azathioprine was added into it and with continuation agitation 
allowed to stand overnight. Azathioprine pectin dispersion was 
added to the CaCl2 
7
solution and provided 2 h for hardening at 60 °C 
of drying for 3 h [ ]. Process parameters such addition rate 1 
ml/min, stirring speed 20 rpm, and nozzle diameter 0.4 mm were 
kept constant during the process. Different batches of beads were 
prepared as per table 1. 
 
Table 1: Formulations of pectin beads 
Batch no. Ratio of pectin: CaCl Azathioprine (mg) 2 
A1 1:1 600 
A2 1:1.5 600 
A3 1:2 600 
A4 1.5:1 600 
A5 1.5:1.5 800 
A6 1.5:2 800 
A7 2:1 800 




The coating operation was performed on fluid bed coater (Remi 
equipment, Mumbai, India). There were 50 g beads of the optimized 
batch were taken into the coating vessels. Blower and heater were 
switched on to achieve the required temperature. The coating 
solution of required strength was prepared and visual 
examination was done for clarity of the solution. Once all the 
preliminary preparation was satisfactory, fluid bed coater was 
started to accomplish the coating process. After completion of the 
process, coated beads were weighted to evaluate coating 
efficiency. During process parameters, inlet air temperature 45 °C, 




Loading amount of pectin and weight of the dried beads of each 
batch were accurately measured. Production yield (percentage 
yield) was determined as per equation Eq. 1. Due care was taken to 
avoid experimental weight loss of beads during the preparation [
, blower speed 900 rpm, and spray rate 2 ml/min were 
kept constant. Three different batches from optimized batch were 
prepared according to different times of coating as 20 min (D1), 40 
min (D2), and 60 min (D3). 
Micrometric properties of beads 
Production yield (percentage yield) 
1]. 
Production Yield (% Yield) = Total mass of beads
Total mass of raw material
 × 100 (1) 
Morphology of beads 
The spherical shape of the beads was one of the crucial parameters 
as it influenced on various other parameters. Properly dried beads 
of each batch were visually observed and morphological effects of 
pectin concentration and CaCl2 1 concentrations were studied [ ].  
Loss of weight during drying (LOD) 
Beads were weighted before and after the drying process to 
determine percentage weight loss as per the Eq. 2. Due care was 
taken to avoid experimental weight loss of beads during the 
preparation [1].  
% Weight loss = Wt−Wo
Wt
 × 100 … …(2) 
Where, 
W0= Weight of dried beads 
Wt
There were 10 g of dried beads dipped in a beaker containing 100 
ml of 0.1N HCl solution. The swollen beads were weighted at 
specified time intervals. After 30 min, there was increased in the 
weight of beads which was considered as the end of the experiment. 
Following Eq. 3 was used to determine the swelling Index [
= Weight of undried beads 
Determination of swelling index 
1].  
Swelling Index = Wa−Wb
Wa
 × 100 … … …(3) 
Where,  
Wa= Initial weight of dried beads,  
Wb= The weight of beads at time t.  
Physical properties of beads 
The study was designed as following to identify the compressibility, 
flowability and particle size of prepared beads. 
Determination of average particle size of beads 
Average bead size was determined by optical microscopy method. 
The properly dried bead was placed on a glass slide which was 
mounted on the stage of the microscope (Olympus, India). The 
calibrated ocular micrometre (Olympus, India) was used to 
measure the diameter of 50 dry beads and mean particle size was 
calculated [8]. 
Bulk density 
Accurately weighted beads were poured into measuring cylinder 
and tapped for three times. The volume occupied by beads was 
measured, known as bulk volume. The bulk density was determined 
as per Eq. 4 [8]. 
Bulk density = Weight of beads
Bulk volume of beads
 (4) 
Tapped density 
Accurately weighted beads were poured into measuring cylinder 
and tapped until the height of beads became constant. The volume 
occupied by beads was measured, known as tapped volume. Tapped 
density was determined as per Eq. 5 [8]. 
Tapped density = Weight of beads
Tapped volume of beads
 (5) 
Determination of flow properties 
Percentage compressibility index and Hausner ratio were 
determined as per the Eq. 6 and 7, respectively [8].  
% 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝐼𝐼𝐼𝐼𝐼𝐼𝐶𝐶𝐼𝐼 = (1 − 𝑉𝑉𝐶𝐶
𝑉𝑉
) × 100 (6) 






V = Tapped volume, 
V0= Bulk Volume, 
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ρ = Tapped density,  
ρ0
Percentage azathioprine loading 
There were 50 mg azathioprine loaded beads were thoroughly 
crushed and placed in a volumetric flask (Borosil
 = Bulk density 
®
The sample from the solution was taken to analyze spectro-
photometrically at λmax nm. The percentage azathioprine loading 
was calculated using Eq. 8 [
) containing 50 ml 
of 7.4 pH phosphate buffer for 1 h. Azathioprine was completely 
extracted from beads to buffer solution by filtration (pore size 11µ). 
8]: 
 
% Azathioprine loading = ( Actual azathioprine content
Theoreticalazathioprine content
) × 100 (8) 
 
Scanning electron microscopy of uncoated beads 
The surface morphology and uniform shape of the prepared 
uncoated and eudragit S100 coated beads were studied using 
scanning electron microscope (Jeol JSM-6380LV, Japan). The 
eudragit S100 coated beads were cut into two halves with the help 
of a sharp cutter, SEM study of the cross-section area of eudragit 
S100 coated beads also showing coating thickness. The samples of 
beads were placed in sample holders and coated with platinum. The 
samples were imaged using a 5kV electron beam [9]. 
In vitro azathioprine release profile 
In vitro release study was used to generate percentage cumulative 
azathioprine release profile of azathioprine loaded beads and to 
identify the retention of azathioprine in upper GI Tract and release 
in the colon. A dissolution study was carried out in 0.1N HCl solution 
(pH-1.2), Phosphate buffer (pH-6.8 and 7.4) using USP type I (basket 
type, Electro Lab, Mumbai, India) dissolution apparatus to 
determine azathioprine release rate.  
Accurately weighed beads were wrapped in a muslin cloth and 
placed in 0.1N HCl solution (pH-1.2) as dissolution media for 2 h 
which would be replaced with phosphate buffer pH-6.8 for 3 h. 
Process parameters such as the volume of dissolution medium, the 
temperature of dissolution medium and rotation speed were kept 
900 ml, 37 °C, and 100 rpm, respectively during the study.   
A sampling of 10 ml was carried out at the interval of every 60 
min and analyzed in UV visible double beam spectrophotometer 
in 0.1N HCl solution (pH-1.2). A sampling of 10 ml was carried 
out at the interval of every 10 min and analyzed in UV visible 
double beam spectrophotometer in phosphate buffer pH-6.8 [9]. 
Determination of coating efficiency 
There were 100 g of prepared beads were coated with 15% eudragit 
S100 solution in fluid bed coater for various time. The coating 
efficiency was determined by Eq. 9 [10]. 
% Coating efficiency = ( Actual weight gain
Theoretical weight gain
) × 100 (9) 
Dissolution kinetic study 
Dissolution kinetic study was assessed for various kinetics like zero 
order, first order, Higuchi model, Hixon-Crowell model and, 
Korsmeyer/Peppa's model and their correlation coefficient (R) 
square values were noted. The best model fit was selected, which 
had the smallest sum of squared residual value [11, 12]. 
Stability study 
Azathioprine loaded beads of the optimized batch were subjected to 
accelerated stability studies in aluminum/aluminum pouch pack as 
the aluminum strip is considered the best protecting packaging 
material but in the present study, the simulation was made using 
aluminum foil pouch. As the dosage form is formulated for site-
specific drug delivery to the colon, no change should occur in its 
drug dissolution profile. The beads of batch D3 were packed in the 
aluminum pouch and charged for accelerated stability studies at 40 
°C and 75% RH for 3 mo in a humidity jar (Remi equipment, 
Mumbai, India). Azathioprine dissolution profile of exposed samples 
was carried out [9]. 
Statistical analysis 
All data were represented as mean±SD of three independent 
experiments. The Wilcoxon test followed by the Dunnett’s multiple 
comparison tests (considering false discovery rate [q]>3.532 as a 
significant level) were performed for in vitro dissolution profile 
between 0.1N HCl after 2 h and in phosphate buffer pH 6.8 after 3 h 
and in vitro dissolution profile of optimized batch in 0.1N HCl after 2 
h between uncoated (A8) and coated (D3) beads. Instant, GraphPad 
Inc., USA was used for statistical analysis. The results were 
considered as significant 95% of confidence level [13].  
RESULTS 
Azathioprine had 279 nm λmax in 0.1N HCl solution (pH-1.2) and 
phosphate buffer (pH-6.8, pH-7.4). The equation for calibration 
curve were y = 0.045x+0.021 (R2 = 0.997), y = 0.037x+0.027 (R2 = 
0.995), and y = 0.0379x+0.0319 (R2 = 0.9959) in 0.1N HCl solution 
(pH-1.2) and phosphate buffer (pH-6.8 and pH-7.4) respectively. 
In differential scanning calorimetry study of a physical mixture of 
azathioprine and excipients (fig. 1), the pick was observed at 245 °C, 
which is the peak of azathioprine. 
  
 
Fig. 1: Differential scanning calorimetry of a physical mixture of azathioprine and excipients. Acquisition weight: 3.22 mg, Atmosphere: 
Nitrogen, Flow rate: 20 ml/min, Temperature: 10–350 °C 
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FTIR of a physical mixture of azathioprine and excipients (fig. 2) had 
been shown peaks at 3191.33 cm-1, 2966.67 cm-1, 2810.38 cm-1, and 
1576.86 cm-1
Scanning electron microscopy of an uncoated (A8) and coated 
optimized (D3) batches of beads were indicated the smooth and 
uniform surface (fig. 3A and B).  which are major bands due to stretching’s of NH group 
and purine ring of azathioprine respectively.  Evolution results of azathioprine loaded beads are represented in table 2. 
 
 
Fig. 2: Fourier transform infrared spectroscopy of a physical mixture of azathioprine and excipients 
 
 
Fig. 3: Scanning electron microscopy of an uncoated optimized batch of beads. A: Uncoated optimized batch (A8). B: eudragit S100 coated 
optimized batch (D3) 
 
Table 2: Evaluation results of beads 
Batch no. % Yield Average mean diameter 
(mm) 
LOD 













A1 64.13±3.13 1.211±0.74 86.34±0.58 2.358±0.12 32.79±1.12 0.662±0.01 0.985±0.03 1.49±0.09 
A2 70.25±5.53 1.193±0.86 85.97±0.46 2.385±0.13 34.11±1.13 0.649±0.02 0.985±0.04 1.52±0.08 
A3 71.23±4.15 1.186±0.79 86.46±0.51 2.556±0.14 28.07±1.21 0.656±0.01 0.912±0.03 1.39±0.07 
A4 78.61±0.92 1.194±0.16 84.74±0.28 2.425±0.15 19.54±1.25 0.696±0.02 0.865±0.02 1.24±0.06 
A5 85.32±1.87 1.175±0.27 85.37±0.31 2.521±0.16 17.93±1.27 0.705±0.03 0.859±0.01 1.22±0.05 
A6 84.27±2.15 1.181±0.19 83.52±0.32 2.495±0.17 18.84±1.11 0.702±0.04 0.865±0.02 1.23±0.04 
A7 86.15±0.89 1.219±0.85 85.28±0.23 2.546±0.18 15.21±1.01 0.708±0.05 0.835±0.03 1.18±0.04 
A8 88.19±1.19 * 1.201±0.19 83.36±0.20 2.654±0.19 17.08±1.02 0.699±0.04 0.843±0.02 1.21±0.05 
*
Table 3: Results of in vitro azathioprine release profile 
Optimized batch; LOD: Loss on drying. Data were represented as mean±SD, n = 3. 
 
Batch No. 1 (% CAR in 
0.1N HCl after 2 h) 
2 (% CAR in phosphate buffer 
pH 6.8 after 3 h) 
3 (Total 
% CAR after 5 h) 
SA 
2 vs 1 
p-value q-value 
A1 33.29±1.31 62.75±2.31 96.04±2.48 0.0039 5.551 
A2 30.17±1.22 66.91±2.45 97.08±3.11 
A3 29.12±1.14 67.36±1.75 96.48±2.24 
A4 23.41±0.88 74.71±1.65 98.12±1.12 
A5 33.83±1.42 64.35±1.42 98.18±2.84 
A6 31.73±1.62 65.87±2.16 97.60±2.27 
A7 30.17±1.48 65.98±1.64 96.15±3.83 
A8 24.97±1.15 * 73.09±1.26 98.06±2.14 
D3 3.24±0.02 ¶ 12.45±0.16 99.64±1.15 
*Uncoated optimized batch; ¶Eudragit S100 coated optimized batch, Data were represented as mean±SD, n = 3, CAR: Cumulative azathioprine 
release, SA: Statistical analysis, p<0.05 and q>3.532 were considered as significant.  
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There was maximum azathioprine release observed in phosphate 
buffer (pH 6.8) after 3 h (table 3).  
Eudragit S100 coating was decreased release of azathioprine release 
in 0.1N HCl after 2 h (p = 0.049, q = 3.533). 
In dissolution kinetic study R2 value for zero order, first order, 
Higuchi model, Hixon-Crowell model and, Korsmeyer/Peppa's 
model were 0.763, 0.7, 0.649, 0.688, and 0.892 respectively. In vitro 
percentage cumulative azathioprine release was identical before and 
after stability study (fig. 4). 
 
 
Fig. 4: Stability study of Eudragit S100 coated optimized batch. Data are represented as mean±SD of five independent experiments 
 
DISCUSSION 
Azathioprine had been shown linearity in the rage of 4–15 µG/ml, 5–
20 µG/ml, and 4–20 µG/ml in 0.1N HCl solution (pH-1.2) and 
phosphate buffer (pH-6.8 and pH-7.4) respectively. DSC and FTIR 
had identical peaks with that of pure azathioprine in compatibility 
study. The study was shown that there was no chemical interaction 
between excipients and azathioprine [14]. 
Results of in vitro azathioprine release were indicated more 
azathioprine release found in phosphate buffer (pH-6.8). Pectin-
CaCl2 15 beads are provided pH-dependent drug release [ ]. With 
respect to the results of in vitro results, the study was succeeded in 
pH-dependent azathioprine delivery.  
R2 the value was maximum in Korsmeyer/Peppa's model. Release 
exponent (n) was higher than 1. The optimized formulation was 
followed super case II transport diffusion mechanism [11, 12]. With 
respect to the results of dissolution kinetic study, the study was 
succeeded in colon targeted azathioprine delivery. 
Dissolution profile, before and after accelerated stability study for 
D3 had found satisfactory and no deviation from normal results. The 
study was prepared stable coated beads of azathioprine.  
CONCLUSION 
The in vitro experimental study had been succeeded in development 
and optimization of stable calcium-pectinate beads of the 
azathioprine-a multi-particulate dosage form for the effective 
treatment of inflammatory bowel disease. The finding provided beads 
of azathioprine, which had maximum azathioprine release in pH 6.8. 
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